Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Oncology Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8884812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.

  1995cited by this paper
• DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.

  1995cited by this paper
• Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events

  1994cited by this paper
• A novel mutant topoisomerase II alpha present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429.

  1994cited by this paper
• Serine 1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitro.

  1994cited by this paper
• Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells.

  1994cited by this paper
• Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.

  1993cited by this paper
• Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the gene.

  1993cited by this paper
• Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells.

  1993cited by this paper
• Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells.

  1992cited by this paper
• Localization of RAP1 and topoisomerase II in nuclei and meiotic chromosomes of yeast

  1992cited by this paper
• DNA topoisomerase-targeting antitumor agents and drug resistance.

  1992cited by this paper
• Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively.

  1992cited by this paper
• Characterization of cDNA encoding the mouse DNA topoisomerase II that can complement the budding yeast top2 mutation.

  1992cited by this paper
• Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.

  1991cited by this paper
• Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.

  1990cited by this paper
• Purification of a DNA supercoiling factor from the posterior silk gland of Bombyx mori.

  1990cited by this paper
• DNA topoisomerase poisons as antitumor drugs.

  1989cited by this paper
• DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage

  1989cited by this paper
• Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.

  1988cited by this paper
• In vitro transcription of eukaryotic genes is affected differently by the degree of DNA supercoiling.

  1988cited by this paper
• Transformation by viral and cellular oncogenes of a mouse BALB/3T3 cell mutant resistant to transformation by chemical carcinogens

  1988cited by this paper
• DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe.

  1987cited by this paper
• Isolation and characterization of novobiocin-resistant BHK cells

  1987cited by this paper
• Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.

  1986cited by this paper
• DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

  1984cited by this paper

• Depletion and mutation of topoisomerase II in animal cells.

  2009cites this paper
• DNA Topoisomerases

  2009cites this paper
• DR1-like element in human topoisomerase IIα gene involved in enhancement of etoposide-induced apoptosis by PPARγ ligand

  2003cites this paper
• DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand.

  2003cites this paper
• Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.

  2002cites this paper
• Atypical multidrug resistance may be associated with catalytically active mutants of human DNA topoisomerase II alpha.

  2001cites this paper
• Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.

  2000cites this paper
• Influence of Cell Cycle and Oncogene Activity upon Topoisomerase IIα Expression and Drug Toxicity

  2000cites this paper
• Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.

  1997cites this paper
• Down-regulation of topoisomerase IIalpha in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3.

  1997cites this paper